Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


UN 'deeply disturbed' by strike on Iran school that killed 160 children
Saudi confirms attempted attack on oil refinery, no damage
At least four killed in Israeli strike on building in Lebanon's Baalbek
Kuwait announces death of child from shrapnel wound
Philippine lawmakers advance impeachment of Vice President Duterte
